New test could spare fragile preemies from unneeded antibiotics
NCT ID NCT06100614
Summary
This study aims to see if a new blood test (for a marker called presepsin) can help doctors safely give fewer antibiotics to very premature babies right after birth. Currently, most of these babies get antibiotics because of infection risk, but very few actually have one. The trial will enroll about 900 babies to see if using the test can cut unnecessary antibiotic use by at least 30% without increasing the risk of missing a real infection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY-ONSET NEONATAL SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Amsterdam UMC
RECRUITINGAmsterdam, North Holland, 1105 AZ, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.